Suppr超能文献

自体人血浆在干细胞培养及组织工程血管移植物构建中的冷冻保存。

Autologous human plasma in stem cell culture and cryopreservation in the creation of a tissue-engineered vascular graft.

作者信息

Zhang Ping, Policha Aleksandra, Tulenko Thomas, DiMuzio Paul

机构信息

Division of Vascular and Endovascular Surgery, Thomas Jefferson University, Philadelphia, Pa.

Division of Vascular and Endovascular Surgery, Thomas Jefferson University, Philadelphia, Pa.

出版信息

J Vasc Surg. 2016 Mar;63(3):805-14. doi: 10.1016/j.jvs.2014.10.015. Epub 2014 Dec 9.

Abstract

OBJECTIVE

Previous work demonstrated the effectiveness of autologous adipose-derived stem cells (ASCs) as endothelial cell (EC) substitutes in vascular tissue engineering. We further this work toward clinical translation by evaluating ASC function after (1) replacement of fetal bovine serum (FBS) with autologous human plasma (HP) in culture and (2) cryopreservation.

METHODS

Human ASCs and plasma, isolated from periumbilical fat and peripheral blood, respectively, were collected from the same donors. ASCs were differentiated in endothelial growth medium supplemented with FBS (2%) vs HP (2%). Proliferation was measured by growth curves and MTT assay. Endothelial differentiation was measured by quantitative polymerase chain reaction, assessment of acetylated low-density lipoprotein uptake, and cord formation after plating on Matrigel (BD Biosciences, San Jose, Calif). Similar studies were conducted before and after cryopreservation of ASCs and included assessment of cell retention on the luminal surface of a vascular graft.

RESULTS

ASCs expanded in HP-supplemented medium showed (1) similar proliferation to FBS-cultured ASCs, (2) consistent differentiation toward an EC lineage (increases in CD31, von Willebrand factor, and CD144 message; acetylated low-density lipoprotein uptake; and cord formation on Matrigel), and (3) retention on the luminal surface after seeding and subsequent flow conditioning. Cryopreservation did not significantly alter ASC viability, proliferation, acquisition of endothelial characteristics, or retention after seeding onto a vascular graft.

CONCLUSIONS

This study suggests that (1) replacement of FBS with autologous HP--a step necessary for the translation of this technology into human use--does not significantly impair proliferation or endothelial differentiation of ASCs used as EC substitutes and (2) ASCs are tolerant to cryopreservation in terms of maintaining EC characteristics and retention on a vascular graft.

摘要

目的

先前的研究表明,自体脂肪来源干细胞(ASC)作为内皮细胞(EC)替代物在血管组织工程中具有有效性。我们通过评估以下两种情况下ASC的功能,将这项工作进一步推进至临床转化阶段:(1)在培养过程中用自体人血浆(HP)替代胎牛血清(FBS);(2)对ASC进行冷冻保存。

方法

分别从同一供体的脐周脂肪和外周血中分离出人ASC和血浆。ASC在添加2% FBS或2% HP的内皮生长培养基中进行分化。通过生长曲线和MTT法测定增殖情况。通过定量聚合酶链反应、乙酰化低密度脂蛋白摄取评估以及接种于基质胶(BD生物科学公司,加利福尼亚州圣何塞)后的成管形成来测定内皮分化情况。在ASC冷冻保存前后进行了类似研究,包括评估细胞在血管移植物管腔表面的留存情况。

结果

在添加HP的培养基中扩增的ASC表现出:(1)与FBS培养的ASC具有相似的增殖能力;(2)向EC谱系的一致分化(CD31、血管性血友病因子和CD144表达增加;乙酰化低密度脂蛋白摄取;以及在基质胶上形成管状物);(3)接种并随后进行流动调节后在管腔表面的留存。冷冻保存并未显著改变ASC的活力、增殖能力、内皮特性的获得或接种到血管移植物后的留存情况。

结论

本研究表明:(1)用自体HP替代FBS(这是将该技术转化为人体应用所必需的一步)不会显著损害用作EC替代物的ASC的增殖或内皮分化;(2)就维持EC特性和在血管移植物上的留存而言,ASC对冷冻保存具有耐受性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验